RSKD:NYSERiskified Ltd. Analysis
Data as of 2026-06-14 - not real-time
$4.94
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The 20‑day moving average sits above both the 50‑day and 200‑day averages, hinting at a modest bullish bias, yet the MACD histogram remains in negative territory and recent volume has been tapering, suggesting weakening momentum. RSI hovers around the mid‑range, and the stock’s volatility is high while its beta tracks closely with the market. Price currently trades between a clear support zone and a resistance ceiling, leaving upside room toward the discounted cash‑flow derived fair value.
Fundamentally, the company posted revenue growth and a healthy gross margin, and the latest quarter showed a dramatic surge in adjusted EBITDA and positive free cash flow, backed by a strong cash pile relative to modest debt. Forward earnings multiples are well below the sector average, and analysts have lifted their price targets, implying a meaningful upside potential. Recent news highlights expanding multi‑product adoption and upgraded guidance, reinforcing a positive outlook.
Fundamentally, the company posted revenue growth and a healthy gross margin, and the latest quarter showed a dramatic surge in adjusted EBITDA and positive free cash flow, backed by a strong cash pile relative to modest debt. Forward earnings multiples are well below the sector average, and analysts have lifted their price targets, implying a meaningful upside potential. Recent news highlights expanding multi‑product adoption and upgraded guidance, reinforcing a positive outlook.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Technical indicators showing mixed momentum
- Proximity to resistance level
- Recent earnings beat and guidance raise
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong EBITDA growth
- Undervalued relative to fair value
- Revenue guidance upside
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Secular demand for fraud mitigation
- Diversified global customer base
- Robust cash position
Key Metrics & Analysis
Financial Health
Revenue Growth7.10%
Profit Margin-5.17%
P/E Ratio13.6
ROE-5.73%
ROA-3.77%
Debt/Equity8.77
P/B Ratio2.6
Op. Cash Flow$39.6M
Free Cash Flow$43.3M
Industry P/E36.8
Technical Analysis
TrendNeutral
RSI56.9
Support$4.40
Resistance$5.09
MA 20$4.83
MA 50$4.61
MA 200$4.63
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86
Valuation
Fair Value$7.14
Target Price$5.55
Upside/Downside12.35%
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.03
Volatility35.21%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.